We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

Back to rankings

270 hedge funds and large institutions have $5.5B invested in CUBIST PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 109 increasing their positions, 86 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 86

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

2% less funds holding

Funds holding: 276 → 270 (-6)

15% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 41

29% less capital invested

Capital invested by funds: $7.7B → $5.5B (-$2.21B)

96% less call options, than puts

Call options by funds: $16.1M | Put options by funds: $446M

Holders
270
Holders Change
-6
Holders Change %
-2.17%
% of All Funds
7.76%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.23%
New
35
Increased
109
Reduced
86
Closed
41
Calls
$16.1M
Puts
$446M
Net Calls
-$430M
Net Calls Change
-$419M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$46.5M
2
PI
Putnam Investments
Massachusetts
+$42.3M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$41.7M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$36.5M
5
HM
HealthCor Management
New York
+$34M

Top Sellers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$576M
2
MC
Maverick Capital
Texas
-$127M
3
EAM
Eagle Asset Management
Florida
-$38.5M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$29.5M
5
CAM
Cormorant Asset Management
Massachusetts
-$21.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Mackenzie Financial
276
Mackenzie Financial
Ontario, Canada
– -$9.81M -134,100 Closed
Adage Capital Partners
277
Adage Capital Partners
Massachusetts
– -$6.21M -84,907 Closed
RSCM
278
Rail-Splitter Capital Management
Illinois
– -$5.56M -76,000 Closed
AL
279
AJO LP
Pennsylvania
– -$5.19M -71,000 Closed
SFM
280
Soros Fund Management
New York
– -$3.66M -50,000 Closed
DCMM
281
DG Capital Management (Massachusetts)
Massachusetts
– -$2.67M -36,460 Closed
SIM
282
Spark Investment Management
New York
– -$1.84M -25,200 Closed
DCM
283
Dupont Capital Management
Delaware
– -$1.35M -18,444 Closed
ARC
284
Absolute Return Capital
Massachusetts
– -$1.16M -15,823 Closed
HCM
285
Highbridge Capital Management
New York
– -$1.16M -15,823 Closed
CPC
286
Cookson Peirce & Co
Pennsylvania
– -$1.08M -14,770 Closed
SFP
287
Santa Fe Partners
New Mexico
– -$1.02M -13,913 Closed
MSE
288
MUFG Securities EMEA
United Kingdom
– -$819K -11,200 Closed
ICRM
289
Insight Capital Research & Management
California
– -$674K -9,213 Closed
CA
290
Commerzbank Aktiengesellschaft
Germany
– -$673K -9,198 Closed
VKH
291
Virtu KCG Holdings
New York
– -$663K -9,067 Closed
PG
292
PEAK6 Group
Illinois
– -$542K -7,969 Closed
VAM
293
Visium Asset Management
New York
– -$386K -5,272 Closed
TH
294
Timber Hill
Connecticut
– -$348K -5,118 Closed
JC
295
JBF Capital
Colorado
– -$373K -5,100 Closed
AL
296
Airain Ltd
Guernsey
– -$348K -4,757 Closed
QSS
297
Quantitative Systematic Strategies
Florida
– -$311K -4,369 Closed
PWS
298
Peloton Wealth Strategists
Indiana
– -$318K -4,350 Closed
LPL Financial
299
LPL Financial
California
– -$317K -4,330 Closed
OI
300
Oakbrook Investments
Illinois
– -$271K -3,700 Closed
9 10 11
12
13

CBST Hedge Fund Activity: Q2 2014 in Review

270 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q2 2014, worth a combined $5.5B — down 29% from $7.7B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of CBST and 35 opened new positions — a net loss of 6 holders — while 86 trimmed existing stakes and 109 added.

The largest buyer was Fidelity Investments, adding an estimated $46.5M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $576M.

  • 270 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q2 2014, down from 276 in Q1 2014.
  • Funds reported $5.5B of CUBIST PHARMACEUTICALS INC stock for Q2 2014, down 29% quarter-over-quarter.
  • 35 funds opened new CUBIST PHARMACEUTICALS INC positions in Q2 2014 and 41 closed out, a net change of -6 holders.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q2 2014 was Fidelity Investments, an estimated $46.5M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q2 2014 was BNP Paribas Financial Markets, an estimated $576M sold.

Based on aggregated 13F filings for Q2 2014.